CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. (Q30487339)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. |
scientific article |
Statements
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy (English)
Kenneth C Anderson
Irene M Ghobrial
Nikhil C Munshi
Teru Hideshima
Abdel Kareem Azab
Feda Azab
Mena Farag
Judith M Runnels
Molly R Melhem
Costas Pitsillides
Anne-Sophie Moreau
Barrett J Rollins
Xiaoying Jia
Renee Wright
Beatriz Ospina
Alicia L Carlson
Clemens Alt
Nicholas Burwick
Hai T Ngo
Charles P Lin
Xavier Leleu
12 January 2009
1 reference
1 reference
1 reference